(NASDAQ: ACET) Adicet Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Adicet Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ACET's revenue for 2024 to be $2,053,849,600, with the lowest ACET revenue forecast at $2,053,849,600, and the highest ACET revenue forecast at $2,053,849,600. On average, 1 Wall Street analysts forecast ACET's revenue for 2025 to be $2,053,849,600, with the lowest ACET revenue forecast at $2,053,849,600, and the highest ACET revenue forecast at $2,053,849,600.
In 2026, ACET is forecast to generate $2,053,849,600 in revenue, with the lowest revenue forecast at $2,053,849,600 and the highest revenue forecast at $2,053,849,600.